U.S. Personal Products Stock News

In February 2026, GDS Holdings Limited closed a US$300,000,000 private placement of Series B Redeemable Convertible Preferred Shares, including participation from Chinese institutional investors and new investor Huatai Capital Investment Limited. Upon full conversion, Huatai Capital Investment Limited would hold 44,096,580 Class A ordinary shares, equal to 2.7% of GDS’s total shares outstanding. At the same time, affiliate DayOne Data Centers has been moving toward a potential US initial...

Broadridge Financial Solutions (NYSE:BR) announced the acquisition of CQG to expand its execution management and digital asset trading capabilities. The company rolled out its Mortgage-Backed Securities Trade Assignment Portal (TAP) with Nissay Asset Management, marking the first adoption of this tool in Japan. Broadridge added Trish Mosconi and Christopher Perry to its Board of Directors, while Brett Keller disclosed plans to resign from the board. Broadridge, trading at $173.7, is moving...

Automatic Data Processing (ADP) is back in focus after fiscal Q2 2026 results beat analyst revenue and adjusted EPS forecasts. However, the stock reaction has been shaped by insider selling and a new US$6b buyback announcement. See our latest analysis for Automatic Data Processing. Despite the Q2 beat and new US$6b buyback, recent sentiment shifts and insider selling have coincided with a 30 day share price return decline of 17.95% and a 1 year total shareholder return decline of 29.64%,...

Matic’s new partnership with nCino (NCNO) brings a home insurance marketplace directly into nCino’s mortgage point of sale product, a move that could matter for investors watching its role in digital lending workflows. See our latest analysis for nCino. nCino’s partnership activity arrives after a weak stretch for the stock, with a 30 day share price return of 34.04% and a 1 year total shareholder return decline of 52.88%, suggesting sentiment has been fading despite ongoing product...

Peabody Energy Corporation has reported its fourth-quarter and full-year 2025 results, with quarterly sales of US$1,022.3 million and net income of US$10.4 million, and a full-year sales figure of US$3,861.5 million alongside a net loss of US$52.9 million, while also declaring a quarterly dividend of US$0.075 per share payable on March 10, 2026. The swing from full-year net income of US$370.9 million in 2024 to a net loss in 2025, even as the board maintained a cash dividend, raises...

On February 12, 2026, CarMax announced that Keith Barr, former CEO of InterContinental Hotels Group, will become its President, CEO, and board member, effective March 16, 2026, with interim leader David McCreight returning to his role as an independent director. The appointment brings a leader with deep experience in customer experience, loyalty programs, and large-scale digital transformation into a business seeking to revamp its operations after a three-year sales slump. We’ll now examine...

In February 2026, Medpace Holdings reported past fourth-quarter 2025 results showing revenue of US$708.45 million and GAAP diluted EPS of US$4.67, alongside full-year 2025 revenue of US$2.53 billion and net income of US$451.12 million. The company also issued 2026 guidance calling for revenue of US$2.76–US$2.86 billion and GAAP diluted EPS of US$16.68–US$17.50, while acknowledging elevated trial cancellations and a softer book-to-bill ratio despite strong new business awards. We’ll now...

Addus HomeCare (ADUS) is back in focus as recent research highlights expected benefits from reimbursement rate increases in Texas and Illinois, alongside a softer labor market that could support hiring in its core Personal Care segment. See our latest analysis for Addus HomeCare. The recent research around reimbursement tailwinds and hiring conditions is landing at a time when momentum appears to be rebuilding, with a 7.48% 7 day share price return and year to date share price return of...

In February 2026, Vertex, Inc. reported fourth-quarter 2025 revenue of US$194.71 million and a net loss of US$7 million, while full-year revenue reached US$748.44 million with net income of US$7.21 million, and it issued 2026 revenue guidance of US$193.5 million–US$196.5 million for Q1 and US$823.5 million–US$831.5 million for the year. The company also installed a new President and CEO, Christopher Young, who is emphasizing AI-powered offerings like smart categorization and Vertex Copilot,...

What Entergy’s Recent Performance Tells You Entergy (ETR) has drawn fresh attention after a steady run in its share price, with returns of 10% over the past month and 11.9% year to date prompting investors to reassess the utility. See our latest analysis for Entergy. That recent 10.4% 30 day share price return sits alongside a 30.9% 1 year total shareholder return, suggesting momentum has been building both in the short term and over a longer holding period. If Entergy’s move has you looking...

Earlier this week, lululemon unveiled its Unrestricted Power™ training platform in North America, introducing PowerLu™ fabric and new men’s and women’s performance pieces designed for heavy lifts and high-intensity workouts. At the same time, recurring transparency complaints about core leggings, leadership turnover, and operational pressures are testing lululemon’s efforts to refresh its product engine and restore customer trust. We’ll now examine how renewed concerns over see-through...

Immatics previously received FDA orphan drug designation for its melanoma therapy targeting Stage II and higher cutaneous melanoma in HLA-A 02:01-positive patients, marking a key regulatory milestone in its immunotherapy pipeline. This orphan status brings potential benefits such as regulatory support and market exclusivity, which can materially shape Immatics’ development and commercialization pathway for this treatment. Next, we’ll examine how the FDA orphan drug designation and its...

Verisk Analytics recently appointed Steven Kauderer as president of its Claims Solutions business, succeeding interim leader and CFO Elizabeth Mann, while reaffirming the unit’s focus on improving claims accuracy, efficiency and speed for insurers and ecosystem partners. This leadership change comes as Verisk’s insurance-focused analytics franchise faces heightened attention following large insured loss estimates from Winter Storm Fern and a more cautious earnings outlook. Against this...

Archer-Daniels-Midland (ADM) is back in focus after director David R. McAtee II bought 7,500 shares shortly after the company reported adjusted fourth quarter EPS above consensus but fell short on revenue with mixed segment results. See our latest analysis for Archer-Daniels-Midland. Despite softer earnings for 2025, investors have pushed Archer-Daniels-Midland’s share price up, with a 30 day share price return of 7.6% and a 1 year total shareholder return of 56.66%. This shows renewed...

Associated Banc-Corp (ASB) has drawn fresh investor attention after reporting record 2025 earnings, beating expectations while unveiling a new US$100 million share repurchase program and reaffirming regular cash dividends. See our latest analysis for Associated Banc-Corp. That backdrop has been reflected in the share price, with a 90 day share price return of 10.08% and a year to date share price return of 8.11%. The 5 year total shareholder return of 72.74% suggests patient investors have...

In early February 2026, Brown-Forman’s King of Kentucky brand released its 2026 Small Batch series, a three-batch, limited-edition bourbon aged 12–18 years and bottled at distinct proofs of 105, 107.5, and 110 to highlight different expressions of its long maturation. This commemorative release, marking both the 250th anniversary of the United States and the creation of Kentucky County, underscores Brown-Forman’s use of scarcity, aging depth, and premium storytelling to reinforce its...

Earnings beat and dividend announcement reshape the Inter & Co (INTR) story Inter & Co (INTR) just paired an earnings beat with a new cash dividend, giving investors fresh income details alongside updated profit figures and recent business expansion milestones. See our latest analysis for Inter & Co. The recent earnings beat and new dividend come after a mixed stretch for the stock, with a 4.4% 30 day share price return but a 5.3% 90 day decline. At the same time, the 1 year total shareholder...

In recent days, NordVPN announced it selected CrowdStrike to power its Threat Protection Pro feature, while CrowdStrike signed a memorandum of understanding with Aramco in Saudi Arabia.

Surgery Partners recently saw increased investor attention as the market reacted to expectations for modest fourth-quarter 2025 revenue growth alongside lower earnings per share compared with the prior year. At the same time, contrasting commentary around its cash flow strength, expansion efforts, and elevated leverage has sharpened the debate over the company’s risk‑reward profile. We’ll now explore how optimism around upcoming results, despite flat earnings estimates, influences Surgery...

Applied Materials Q1 2026 earnings snapshot Applied Materials (AMAT) kicked off fiscal 2026 with Q1 revenue of about US$7.0b and basic EPS of US$2.55, supported by trailing 12 month EPS of US$9.81 on revenue of roughly US$28.2b. Over recent quarters the company has seen revenue move between US$7.3b and US$6.8b, while quarterly basic EPS has ranged from US$1.46 to US$2.64. This gives investors a clearer picture of how the top and bottom lines have tracked together. With trailing net profit...

LifeStance Health Group is facing operational challenges that are coinciding with continued value pressure as it pursues growth. Concerns center on subscale operations, limited distribution channels relative to peers, and a track record of negative returns on capital tied to its expansion efforts. These issues raise fresh questions about the long term competitiveness and profitability of NasdaqGS:LFST for current and potential shareholders. LifeStance Health Group, trading on NasdaqGS:LFST...

WeShop Holdings (NasdaqCM:WSHP) is expanding its marketplace into the health and fitness category with leading global brands. The company is rolling out new platform features focused on user trust, safety, and a smoother onboarding process. Key additions include a two-layer content moderation system and username reservation to support community growth and retention. For you as an investor, this move places NasdaqCM:WSHP in the middle of two large, active online segments: e-commerce and...

In recent days, Box has drawn attention after Jim Cramer highlighted it as a document storage and collaboration software company he views as potentially undervalued, while CEO Aaron Levie pushed back against concerns that AI will drive enterprises away from third‑party tools. Adding to this, DA Davidson named Box one of its top software picks for 2026, citing customer upgrades to the Enterprise Advanced tier as a key driver of anticipated sales momentum. Next, we’ll examine how analyst...

Humana (HUM) is back in focus after its fourth quarter 2025 results and 2026 outlook pointed to lower expected profitability, with Medicare Advantage Star Ratings creating a sizeable earnings headwind despite higher revenue and membership. See our latest analysis for Humana. The recent guidance cut and Stars headwind have gone hand in hand with a sharp reset in expectations, with a 30 day share price return of 32.84% decline and a 1 year total shareholder return of 26.46% decline pointing to...